QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=DE304EC9CDF11B7124964268841F1366;jsessionid=C57F5F3FC8F419FF7AD96B2ECA778D7B;jsessionid=B287443DB6C5648B246227826DD6A555;jsessionid=2F68833EFF7812B19476AF7667E3CE8E;jsessionid=4A4E76BA4BFA450B01A2E74E66021C2B;jsessionid=AC7703FF935EB4642C74E0B3B3732FC1;jsessionid=D7A4B443A56E3BA50FD78FB9289B6201 (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
4. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.
5. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=DE304EC9CDF11B7124964268841F1366;jsessionid=C57F5F3FC8F419FF7AD96B2ECA778D7B;jsessionid=B287443DB6C5648B246227826DD6A555;jsessionid=2F68833EFF7812B19476AF7667E3CE8E;jsessionid=4A4E76BA4BFA450B01A2E74E66021C2B;jsessionid=AC7703FF935EB4642C74E0B3B3732FC1;jsessionid=D7A4B443A56E3BA50FD78FB9289B6201